Recruiting PHASE4 INTERVENTIONAL 1-arm NCT05557279

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks - a Single-center Study

Sponsor: Loyola University

Conditions Overactive Bladder

Interventions 500 mg NDS-446

Updated 9 times since 2022 Last updated: Sep 2, 2025 Started: Jan 1, 2023 Primary completion: Dec 1, 2025 Completion: Dec 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Overactive Bladder, this trial is actively recruiting participants. The trial is conducted by Loyola University and has accumulated 9 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Oct 2025 — Present [monthly]

Recruiting PHASE4
Apr 2025 — Oct 2025 [monthly]

Recruiting PHASE4
Sep 2024 — Apr 2025 [monthly]

Recruiting PHASE4
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE4

▶ Show 4 earlier versions

Jan 2024 — Jul 2024 [monthly]

Recruiting PHASE4
Feb 2023 — Jan 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Nov 2022 — Feb 2023 [monthly]

Not Yet Recruiting PHASE4
Sep 2022 — Nov 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Loyola University

Data source: Loyola University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maywood, United States